REQUEST A DEMO
Total
USD $0.00
Search more companies

Dallas Formulations Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Dallas Formulations Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dallas Formulations Private Limited is an unlisted company, incorporated on 24/11/2000. It has its registered office in the State of Madhya Pradesh, India. Company's corporate identification number (CIN) is U24233MP2000PTC014476 and registration number is 014476. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
220,Block-C, 2Nd Floor Madhav Club Road, Dawa Bazar
Ujjain; Madhya Pradesh; Postal Code: 456010

Contact Details: Purchase the Dallas Formulations Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Dallas Formulations Private Limited report to view the information.
Outstanding Shares:
Purchase the Dallas Formulations Private Limited report to view the information.
Registered Capital:
Purchase the Dallas Formulations Private Limited report to view the information.
Incorporation Date:
November 24, 2000
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Company Performance
Financial values in the chart are available after Dallas Formulations Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.6%
Total operating revenue
-16.06%
Operating profit (EBIT)
-51.86%
EBITDA
-28.8%
Net Profit (Loss) for the Period
-77.24%
Total assets
4.87%
Total equity
0.7%
Operating Profit Margin (ROS)
-0.88%
Net Profit Margin
-0.96%
Return on Equity (ROE)
-2.39%
Debt to Equity Ratio
-4.98%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?